A review in the Canadian Journal of Physiology and Pharmacology examines emerging evidence linking glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the gut microbiome, and obesity treatment ...
Spread the loveAs the popularity of GLP-1 receptor agonists like semaglutide and tirzepatide continues to rise for weight management, emerging research suggests that these medications may come with ...
An Informational Consumer Analysis of AgelessRx's Prescription Process, NAD+ Therapies, GLP-1 and Compounded Semaglutide Options, Off-Label Longevity Medications, and Cash-Pay Pricing Structure for 20 ...
Medications known as GLP-1 receptor agonists have become some of the most popular treatments for weight loss in recent years. These drugs, originally developed to help people with diabetes control ...
GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.
The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use disorders (SUDs).
Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...
Twenty point six percent of patients followed a switcher trajectory within 12 months, with higher persistence seen for switchers.
For many people, recovery from a heart attack is a journey that requires careful lifestyle tweaks and long-term medication ...
Taking magnesium with a GLP-1 like Ozempic? Learn how they can interact, potential digestive effects, and key safety tips.
Recently, there has been a lot of news around the use of peptides in health circles. The U.S. Department of Health and Human Services recently announced that bans on 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results